Advertisement
Screener

CIDARA THERAPEUTICS, INC. Financing Cash Flow

CIDARA THERAPEUTICS, INC. Financing Cash Flow

CIDARA THERAPEUTICS, INC. reported Financing Cash Flow of $383.62 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-06

  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $160.00K.
  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $383.38M, a 60.32% increase year-over-year.
  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $77.00K.
  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $98.20M, a 1227462.50% increase year-over-year.
  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $337.06M, a 1197.19% increase from fiscal 2023.
  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $25.98M.
  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$951.00K, a 102.13% decline from fiscal 2021.
  • CIDARA THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2021 was $44.60M, a 19.63% increase from fiscal 2020.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2025-09-30$160.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$383.55M
derived: sum of 2 quarters · filed 2025-11-06
$383.62M
10-Q · filed 2025-11-06
$481.83M
derived: sum of 4 quarters · filed 2025-11-06
2025-06-30$383.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$383.46M
10-Q · filed 2025-08-07
$481.67M
derived: sum of 3 quarters · filed 2025-08-07
$481.49M
derived: sum of 4 quarters · filed 2025-11-06
2025-03-31$77.00K
10-Q · filed 2025-05-08
$98.28M
derived: sum of 2 quarters · filed 2025-05-08
$98.10M
derived: sum of 3 quarters · filed 2025-11-06
$337.23M
derived: sum of 4 quarters · filed 2025-11-06
2024-12-31$98.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$98.02M
derived: sum of 2 quarters · filed 2025-11-06
$337.15M
derived: sum of 3 quarters · filed 2025-11-06
$337.06M
10-K · filed 2025-03-06
2024-09-30-$182.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$238.95M
derived: sum of 2 quarters · filed 2025-11-06
$238.86M
10-Q · filed 2025-11-06
$238.86M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$239.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$239.04M
10-Q · filed 2025-08-07
$239.05M
derived: sum of 3 quarters · filed 2025-08-07
$239.05M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$93.00K
10-Q · filed 2025-05-08
-$85.00K
derived: sum of 2 quarters · filed 2025-05-08
-$85.00K
derived: sum of 3 quarters · filed 2025-05-08
-$346.00K
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$8.00K
derived: sum of 2 quarters · filed 2025-03-06
-$253.00K
derived: sum of 3 quarters · filed 2025-03-06
$25.98M
10-K · filed 2025-03-06
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$261.00K
derived: sum of 2 quarters · filed 2024-11-07
$25.98M
10-Q · filed 2024-11-07
$26.64M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$261.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$25.98M
10-Q · filed 2024-08-13
$26.64M
derived: sum of 3 quarters · filed 2024-08-13
$26.75M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$26.24M
10-Q · filed 2024-05-15
$26.90M
derived: sum of 2 quarters · filed 2024-05-15
$27.01M
derived: sum of 3 quarters · filed 2024-05-15
$25.90M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$664.00K
derived: 10-K 12 month − 10-K 9 month · filed 2024-04-22
$771.00K
derived: sum of 2 quarters · filed 2024-04-22
-$340.00K
derived: sum of 3 quarters · filed 2024-04-22
-$951.00K
10-K · filed 2024-04-22
2022-09-30$107.00K
derived: 10-K 9 month − 10-K 6 month · filed 2024-04-22
-$1.00M
derived: sum of 2 quarters · filed 2024-04-22
-$1.61M
10-K · filed 2024-04-22
$35.26M
derived: sum of 4 quarters · filed 2024-04-22
2022-06-30-$1.11M
derived: 10-K 6 month − 10-K 3 month · filed 2024-04-22
-$1.72M
10-K · filed 2024-04-22
$35.15M
derived: sum of 3 quarters · filed 2024-04-22
$34.34M
derived: sum of 4 quarters · filed 2024-04-22
2022-03-31-$611.00K
10-K · filed 2024-04-22
$36.26M
derived: sum of 2 quarters · filed 2024-04-22
$35.45M
derived: sum of 3 quarters · filed 2024-04-22
$36.34M
derived: sum of 4 quarters · filed 2024-04-22
2021-12-31$36.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$36.06M
derived: sum of 2 quarters · filed 2023-03-23
$36.95M
derived: sum of 3 quarters · filed 2023-03-23
$44.60M
10-K · filed 2023-03-23
2021-09-30-$810.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$77.00K
derived: sum of 2 quarters · filed 2022-11-03
$7.72M
10-Q · filed 2022-11-03
$8.13M
derived: sum of 4 quarters · filed 2023-03-23
2021-06-30$887.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$8.53M
10-Q · filed 2022-08-09
$8.94M
derived: sum of 3 quarters · filed 2023-03-23
$12.66M
derived: sum of 4 quarters · filed 2023-03-23
2021-03-31$7.64M
10-Q · filed 2022-05-11
$8.05M
derived: sum of 2 quarters · filed 2023-03-23
$11.77M
derived: sum of 3 quarters · filed 2023-03-23
$15.71M
derived: sum of 4 quarters · filed 2023-03-23
2020-12-31$409.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$4.13M
derived: sum of 2 quarters · filed 2023-03-23
$8.07M
derived: sum of 3 quarters · filed 2023-03-23
$37.28M
10-K · filed 2023-03-23
2020-09-30$3.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$7.66M
derived: sum of 2 quarters · filed 2021-11-10
$36.87M
10-Q · filed 2021-11-10
$38.51M
derived: sum of 4 quarters · filed 2022-03-07
2020-06-30$3.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$33.15M
10-Q · filed 2021-08-12
$34.79M
derived: sum of 3 quarters · filed 2022-03-07
$47.42M
derived: sum of 4 quarters · filed 2022-03-07
2020-03-31$29.21M
10-Q · filed 2021-05-13
$30.85M
derived: sum of 2 quarters · filed 2022-03-07
$43.48M
derived: sum of 3 quarters · filed 2022-03-07
$43.48M
derived: sum of 4 quarters · filed 2022-03-07
2019-12-31$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07
$14.27M
derived: sum of 2 quarters · filed 2022-03-07
$14.27M
derived: sum of 3 quarters · filed 2022-03-07
$14.27M
10-K · filed 2022-03-07
2019-09-30$12.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$12.63M
derived: sum of 2 quarters · filed 2020-11-05
$12.63M
10-Q · filed 2020-11-05
$12.62M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
$0.00
10-Q · filed 2020-08-13
-$12.00K
derived: sum of 3 quarters · filed 2021-02-25
2019-03-31$0.00
10-Q · filed 2020-05-13
-$12.00K
derived: sum of 2 quarters · filed 2021-02-25
2018-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$56.15M
10-K · filed 2021-02-25
2018-09-30$56.16M
10-Q · filed 2019-11-08
2017-12-31$20.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04
$20.88M
10-K · filed 2020-03-04
2017-09-30$73.00K
10-Q · filed 2018-11-08
2016-12-31$37.09M
10-K · filed 2019-02-28